Chest Mobility Exercises Versus Proprioceptive Neuromuscular Facilitation in Patients With COPD

Not Applicable

Completed

• Conditions: Chronic Obstructive Pulmonary Disease Moderate

• Registration Number: NCT06269029
• Lead Sponsor: Cairo University

Brief Summary

Chest mobility exercise versus proprioceptive neuromuscular facilitation in patients with chronic obstructive pulmonary disease

Detailed Description

The purpose of this study is designed to compare the therapeutic effect of chest mobility exercises and proprioceptive neuromuscular facilitation stretching on improving chest expansion and functional capacity in patients with chronicobstructivepulmonarydisease?

Study Timeline

• Study First Submitted: 2024-01-17
• Study Start: 2024-02-17
• Study First Submitted QC: 2024-02-17
• Study First Posted: 2024-02-21
• Primary Completion: 2024-06-30
• Study Completion: 2024-06-30
• Status Verified: 2024-07
• Last Update Submitted: 2024-07-18
• Last Update Posted: 2024-07-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 60

Inclusion Criteria

All patients will have the following criteria:

1. Age: 50-60 years old
2. All patients will be in mild to moderate of COPD. In accordance with criteria of Global Initiative for Chronic Obstructive Lung Disease (GOLD) (GOLD I-II).
3. BMI: obese class 1 (30-34.9).
4. Sex: male
5. They suffered from mild dyspnea, chronic cough and expectorations, with forced expiratory volume in one second (FEV1sec) from 50% to 80% of predicted value.

Exclusion criteria:

Patients with the following criteria will excluded from the study:

1. Severe psychiatric or cognitive impairments.
2. Progressive neuromuscular disorders.
3. Decreased level of consciousness.
4. Unstable fracture.
5. pacemaker inserted for fewer than 2 days
6. Deep-venous thrombosis (to minimize risk for pulmonary embolism from being in a prone position.
7. Mean arterial blood pressure of less than 65 mm Hg with or without vasopressors.
8. Tracheal surgery or sternotomy in the last 15 days.
9. Massive haemoptysis.
10. Intracranial pressure of more than 30 mm Hg or cerebral perfusion pressure of less than 60 mm Hg.

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Pulmonary function test	One week for each comparator	Spirometry is the most common pulmonary function test. It is widely used in the assessment of lung function to provide objective information used in the diagnosis of lung diseases and monitoring lung health Test started at the time of 20 minutes after subjects inhaling 400 μg of salbutamol. The following variables were assessed: FVC, FEV1, inspiratory capacity (IC), and inspiratory reserve volume (IRV)

Trial Locations

Locations (1)

Cairo university- faculty of physical therapy; 🇪🇬 Cairo, Dokki, Egypt